Whether your organization lacks formal clinical trial data disclosure policies and procedures or has longstanding SOPs in place, just how efficient is your disclosure process?


That’s the question that UCB answered with a third-party compliance assessment, reviewing clinical trial disclosure requirements specific to the FDAAA Final Rule, and an assessment of study records and related SOPs. Join us for an informational webinar as Liz Roberts of UCB shares insights on her organization’s decision to commission a compliance assessment focused on the FDAAA/Final Rule requirements and the outcome of that assessment.


Learning objectives:
  • The latest FDA and EU requirements
  • Disclosure best practices
  • What to do before and after a commissioned compliance assessment
Presented by:
  • Liz Roberts

    Global Public Policy Lead

    UCB

  • Thomas Wicks

    Chief Strategy Officer
    TrialScope